JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fielding, S.
Right arrow Articles by Lal, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fielding, S.
Right arrow Articles by Lal, H.

A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions

S Fielding, J Wilker, M Hynes, M Szewczak, WJ Novick and H Lal

Clonidine was found to possess dose-dependent analgesic and antiwithdrawal activity. In mice, clonidine prolonged the tail flick latency and inhibited phenylquinone-induced writhing. In rats, it inhibited tail withdrawal from hot water and a pain response to pressure application on an inflamed paw. The effective doses of clonidine were different in the different tests employed, but they were always smaller than those of morphine. Naloxone failed to antagonize the analgesic actions of clonidine but effectively antagonized those of morphine. Phenoxybenzamine also did not alter the inhibition of tail flick-induced by clonidine. Clonidine suppressed morphine withdrawal body shakes in a dose-dependent manner as does morphine. This action of clonidine was not reversed by naloxone. In usual laboratory tests, clonidine appears to be an effective analgesic which antagonizes signs of morphine withdrawal.

Volume 207, Issue 3, pp. 899-905, 12/01/1978
Copyright © 1978 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
D. J. Kelly, M. Ahmad, and S. J. Brull
Preemptive analgesia I: physiological pathways and pharmacological modalities : [L'analgesie preventive I : mecanismes physiologiques et modalites pharmacologiques]
Can J Anesth, November 1, 2001; 48(10): 1000 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Gutkowska, S. Mukaddam-Daher, and J. Tremblay
The Peripheral Action of Clonidine Analog ST-91: Involvement of Atrial Natriuretic Factor
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 670 - 676.
[Abstract] [Full Text]

Home page
 ScienceHome page
A. Glassman, W. Jackson, B. Walsh, S. Roose, and B Rosenfeld
Cigarette craving, smoking withdrawal, and clonidine
Science, November 16, 1984; 226(4676): 864 - 866.
[Abstract] [PDF]

Home page
 ScienceHome page
D. Franz, D. Hare, and K. McCloskey
Spinal sympathetic neurons: possible sites of opiate-withdrawal suppression by clonidine
Science, March 26, 1982; 215(4540): 1643 - 1645.
[Abstract] [PDF]

Home page
 ScienceHome page
G Kunos, C Farsang, and M. Ramirez-Gonzales
beta-Endorphin: possible involvement in the antihypertensive effect of central alpha-receptor activation
Science, January 2, 1981; 211(4477): 82 - 84.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics.